featured
Evidence Regarding Aducanumab Use in Symptomatic Alzheimer Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee
Neurology 2022 Apr 12;98(15)619-631, GS Day, N Scarmeas, R Dubinsky, K Coerver, A Mostacero, B West, SR Wessels, MJ ArmstrongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.